Jefferies Financial Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $232K | Hold |
317,625
| – | – | ﹤0.01% | 834 |
|
|
2025
Q1 | $256K | Buy |
317,625
+10,000
| +3% | +$8.07K | ﹤0.01% | 1067 |
|
|
2024
Q4 | $425K | Buy |
307,625
+25,000
| +9% | +$34.5K | ﹤0.01% | 891 |
|
|
2024
Q3 | $294K | Buy |
282,625
+86,000
| +44% | +$89.4K | ﹤0.01% | 864 |
|
|
2024
Q2 | $340K | Hold |
196,625
| – | – | ﹤0.01% | 842 |
|
|
2024
Q1 | $470K | Buy |
196,625
+113,000
| +135% | +$270K | ﹤0.01% | 806 |
|
|
2023
Q4 | $278K | Buy |
83,625
+43,000
| +106% | +$143K | ﹤0.01% | 1000 |
|
|
2023
Q3 | $152K | Buy |
+40,625
| New | +$152K | ﹤0.01% | 969 |
|
|
2023
Q2 | – | Sell |
-130,625
| Closed | -$893K | – | 1228 |
|
|
2023
Q1 | $893K | Buy |
130,625
+106,000
| +430% | +$725K | 0.01% | 583 |
|
|
2022
Q4 | $195K | Buy |
+24,625
| New | +$195K | ﹤0.01% | 856 |
|